Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
25.32
+0.37 (1.48%)
Nov 13, 2026, 4:00 PM EST - Market closed

Collegium Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
144.8231.2570.57238.95173.69186.43
Short-Term Investments
-155.4392.271.6--
Cash & Short-Term Investments
144.8386.68162.76310.55173.69186.43
Cash Growth
-49.35%137.57%-47.59%78.80%-6.83%7.07%
Receivables
310.79211.33228.54179.53183.12105.84
Inventory
88.240.9135.5632.3346.517.39
Prepaid Expenses
48.1226.9321.9411.0511.495.85
Restricted Cash
19.8519.8525---
Other Current Assets
-5.728.454.155.20.03
Total Current Assets
611.75691.41482.26537.6419.99315.54
Property, Plant & Equipment
15.316.220.1522.0126.3827.14
Goodwill
193.89145.93162.33133.86133.7-
Other Intangible Assets
1,135669.51891.4421.71567.47268.72
Long-Term Deferred Tax Assets
126.25112.5498.0326.2623.9578.04
Other Long-Term Assets
14.2121.259.421.872.652.63
Total Assets
2,0961,6571,6641,1431,174692.08

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
10.4310.663.938.693.494.19
Accrued Expenses
308.09227.32251.55185.26193.07167.75
Current Portion of Long-Term Debt
60.52964.58183.33162.548.35
Current Portion of Leases
1.61.411.270.991.110.81
Current Income Taxes Payable
1.843.38.532.14-0.62
Current Unearned Revenue
1.780.67----
Other Current Liabilities
218.85167.67179.6477.5173.5557.84
Total Current Liabilities
603.09440.03509.51457.92433.73279.57
Long-Term Debt
1,142901.89908.52483.84538.45201.63
Long-Term Leases
3.94.135.546.127.117.95
Long-Term Unearned Revenue
8.619.1110---
Other Long-Term Liabilities
22.32-1.18---
Total Liabilities
1,7991,3551,435947.88979.29489.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.040.040.040.040.040.04
Additional Paid-In Capital
638.83624.95590.25565.95538.07502.1
Retained Earnings
-79.93-101.13-164-233.19-281.34-256.34
Treasury Stock
-262.51-222.51-197.51-137.38-61.92-42.86
Comprehensive Income & Other
-0.320.060.01--
Shareholders' Equity
296.44301.68228.84195.43194.84202.93
Total Liabilities & Equity
2,0961,6571,6641,1431,174692.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,208936.43979.91674.28709.18258.75
Net Cash (Debt)
-1,063-549.75-817.15-363.74-535.49-72.32
Net Cash Growth
------
Net Cash Per Share
-30.35-13.85-20.21-8.70-15.83-1.76
Filing Date Shares Outstanding
31.0831.7531.4931.9634.0733.38
Total Common Shares Outstanding
31.0731.7131.4431.8733.8533.66
Working Capital
8.67251.38-27.2579.69-13.7435.98
Book Value Per Share
9.549.517.286.135.766.03
Tangible Book Value
-1,032-513.76-824.89-360.13-506.32-65.8
Tangible Book Value Per Share
-33.21-16.20-26.24-11.30-14.96-1.95
Machinery
-25.5825.8324.624.9718.46
Construction In Progress
-1.750.8--5.18
Leasehold Improvements
-1.231.231.060.870.54
SEC Filings: 10-K · 10-Q